Michelle Lofwall

Has grant

Professor

University of Kentucky College of Medicine

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Michelle Lofwall is a Professor at the University of Kentucky College of Medicine, USA. Her research focuses on opioid use disorder, harm reduction strategies, and health-related quality of life associated with substance use. Recent publications include studies on naloxone distribution, the impact of community interventions on opioid overdose education, and the prescribing characteristics of buprenorphine. She is actively involved in exploring innovative approaches to managing opioid addiction and improving patient outcomes.

Recent Grants

Grant: Close

DAT- Integrated Outpatient Treatment of Opioid Use Disorder and Injection-Related Infections

Open Date: 2020-09-30

Close Date: 2024-08-31

Grant: Close

Efficacy of Extended Release Tramadol for Treating Prescription Opioid Withdrawal

Open Date: 2009-08-15

Close Date: 2013-07-31

Articles (20)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

University Research Professor

University of Kentucky

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Michelle Lofwall

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (20)

Letter to the Editor: Correction and clarification to McMaster (2024)

Effect of the Communities That HEAL Intervention on Overdose Education and Naloxone Distribution: A Cluster-Randomized, Wait-List Controlled Trial

Trauma Prevalence and Its Association With Health-related Quality of Life in Pregnant Persons With Opioid Use Disorder

Effect of the Communities that HEAL intervention on receipt of behavioral therapies for opioid use disorder: A cluster randomized wait-list controlled trial

A social history of opioids’ crimedical cycle

Buprenorphine Prescribing Characteristics Following Relaxation of X-Waiver Training Requirements

Community-Based Cluster-Randomized Trial to Reduce Opioid Overdose Deaths

Exploring Opioid Use Disorder Outcomes by Quantitative Urinalysis: Post Hoc Analysis of a Phase 3 Randomized Clinical Trial

Extended-Release 7-Day Injectable Buprenorphine for Patients with Minimal to Mild Opioid Withdrawal

Extended-Release Injection vs Sublingual Buprenorphine for Opioid Use Disorder with Fentanyl Use: A Post Hoc Analysis of a Randomized Clinical Trial

Community selected strategies to reduce opioid-related overdose deaths in the HEALing (Helping to End Addiction Long-term SM) communities study

Changes in transmucosal buprenorphine utilization for opioid use disorder treatment during the COVID-19 pandemic in Kentucky

Design and protocol of the Buprenorphine plus Outpatient Parenteral Antimicrobial Therapy (B-OPAT) study: a randomized clinical trial of integrated outpatient treatment of opioid use disorder and severe, injection-related infections

Dismantling War on Drugs Policies in COVID-19's Aftermath

Opioid Use-Related Stigma and Health Care Decision-Making

Protocol for community-driven selection of strategies to implement evidence-based practices to reduce opioid overdoses in the HEALing Communities Study: a trial to evaluate a community-engaged intervention in Kentucky, Massachusetts, New York and Ohio

Psychometric evaluation of two indices assessing stigma toward opioid misuse and treatment among health care providers

Recent Increase in Methamphetamine Use in a Cohort of Rural People Who Use Drugs: Further Evidence for the Emergence of Twin Epidemics

Acute administration of oxycodone, alcohol, and their combination on simulated driving—preliminary outcomes in healthy adults

Adaptation of a standard extended-release naltrexone (XR-NTX) protocol for rural re-entering offenders with OUD

Collaborators (7)

Hannah Knudsen

VANESSA LOUKAS

Laura Fanucchi

April Young

T Winhusen

Patricia Freeman

CARRIE OSER

Make your next move.